Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Approaching object detection system
Thermoplastic fluoropolymer composition
Article based on a composition containing a crosslinked blend of elastomers
Method for producing an adhesive fastening element made of plastic
Zoom lens
Method and apparatus to maintain welding current to compensate for deterioration of welding contact tip
  Randomly Featured Patents
Secretarial answering system
Leak-proof lead barrier system
Polarization maintaining fiber interferometer and method for source stabilization
Calibrated conduit caliper and method
Composite of sheet metal parts
Cooling apparatus for vertically stacked printed circuit boards
System and method for operating a steam turbine with improved control information display
Methods and computer program products that conditionally route print files
Temperature sampling in electronic devices